ALPHARETTA, Ga., Aug. 8, 2023
/PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced
that Michael Greiner, senior vice president, chief financial
officer, and chief transformation officer will participate in a
fireside chat at the UBS MedTech, Tools and Genomics Summit 2023 on
Tues., Aug. 15 at approximately 1:00 p.m. Pacific
Time.
A webcast of the conference presentation will be available on
the Investors section of the Avanos Medical website and
will be archived on that site.
About Avanos Medical, Inc.
Avanos Medical, Inc. (NYSE: AVNS) is a medical technology
company focused on delivering clinically superior medical device
solutions that will help patients get back to the things that
matter. Headquartered in Alpharetta,
Georgia, we are committed to addressing some of today's most
important healthcare needs, including providing a vital lifeline
for nutrition to patients from hospital to home, and reducing the
use of opioids while helping patients move from surgery to
recovery. We develop, manufacture and market our recognized brands
globally and hold leading market positions in multiple categories
across our portfolio. For more information, visit Avanos.com and
follow Avanos Medical on Twitter (@AvanosMedical), LinkedIn and
Facebook.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-present-at-the-ubs-medtech-tools-and-genomics-summit-2023-301896335.html
SOURCE Avanos Medical, Inc.